Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Other Share Holders Equity 2010-2025 | MKKGY

Merck other share holders equity from 2010 to 2025. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Merck other share holders equity for the quarter ending March 31, 2025 was $2.596B, a 7.54% decline year-over-year.
  • Merck other share holders equity for 2024 was $3.731B, a 66.3% increase from 2023.
  • Merck other share holders equity for 2023 was $2.244B, a 31% decline from 2022.
  • Merck other share holders equity for 2022 was $3.251B, a 50.67% increase from 2021.
  
Merck Annual Other Share Holders Equity
(Millions of US $)
2024 $3,731
2023 $2,244
2022 $3,251
2021 $2,158
2020 $216
2019 $0
2018 $348
2017 $-313
2016 $1,727
2015 $1,536
2014 $1,226
2013 $1,545
2012 $1,668
2011 $1,750
2010 $0
2009 $0
Merck Quarterly Other Share Holders Equity
(Millions of US $)
2025-03-31 $2,596
2024-12-31 $3,731
2024-09-30 $1,978
2024-06-30 $3,007
2024-03-31 $2,808
2023-12-31 $2,244
2023-09-30 $3,409
2023-06-30 $2,793
2023-03-31 $2,705
2022-12-31 $3,251
2022-09-30 $5,092
2022-06-30 $3,790
2022-03-31 $2,345
2021-12-31 $2,158
2021-09-30 $1,501
2021-06-30 $940
2021-03-31 $1,237
2020-12-31 $216
2020-09-30 $1,132
2020-06-30 $2,037
2020-03-31 $2,427
2019-12-31
2019-09-30 $2,742
2019-06-30
2019-03-31 $621
2018-12-31 $348
2018-09-30 $229
2018-06-30
2018-03-31 $-741
2017-12-31 $-313
2017-09-30 $-150
2017-06-30 $541
2017-03-31 $1,566
2016-12-31 $1,727
2016-09-30 $326
2016-06-30 $696
2016-03-31 $556
2015-12-31 $1,611
2015-09-30 $2,541
2015-06-30 $2,797
2015-03-31 $3,004
2014-12-31 $1,226
2014-09-30 $1,015
2014-06-30 $594
2014-03-31 $1,570
2013-12-31 $1,545
2013-09-30 $1,598
2013-06-30 $1,623
2013-03-31 $1,718
2012-12-31 $1,668
2012-09-30 $1,649
2012-06-30 $1,679
2012-03-31
2011-12-31 $1,750
2011-09-30
2011-06-30 $1,869
2011-03-31
2010-12-31
2010-09-30 $76
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.002B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $88.413B 33.17
Zoetis (ZTS) United States $73.286B 27.34
Takeda Pharmaceutical (TAK) Japan $47.888B 9.53
Daiichi Sankyo, - (DSNKY) Japan $46.809B 23.99
BeOne Medicines - (ONC) Cayman Islands $28.882B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Summit Therapeutics (SMMT) United States $16.012B 0.00
United Therapeutics (UTHR) United States $14.813B 13.10
Shionogi (SGIOY) Japan $14.530B 14.56
Neurocrine Biosciences (NBIX) United States $12.443B 42.62
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $9.974B 0.00
Corcept Therapeutics (CORT) United States $7.484B 60.84
Stevanato Group S.p.A (STVN) Italy $7.071B 43.24
Madrigal Pharmaceuticals (MDGL) United States $6.222B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.071B 0.00
Ionis Pharmaceuticals (IONS) United States $5.851B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $3.917B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.152B 11.04
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.022B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.385B 12.90
BioCryst Pharmaceuticals (BCRX) United States $2.325B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.263B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.183B 0.00
Indivior (INDV) United States $1.852B 7.85
Dyne Therapeutics (DYN) United States $1.637B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.595B 0.00
Evotec AG (EVO) Germany $1.463B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Ocular Therapeutix (OCUL) United States $1.418B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Harrow (HROW) United States $1.106B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.100B 22.00
Akebia Therapeutics (AKBA) United States $1.006B 0.00
Enliven Therapeutics (ELVN) United States $0.998B 0.00
Collegium Pharmaceutical (COLL) United States $0.978B 5.28
Avadel Pharmaceuticals (AVDL) Ireland $0.974B 0.00
Ardelyx (ARDX) United States $0.900B 0.00
Cronos Group (CRON) Canada $0.756B 0.00
KalVista Pharmaceuticals (KALV) United States $0.734B 0.00
Elite Pharmaceuticals (ELTP) United States $0.725B 0.00
Xeris Biopharma Holdings (XERS) United States $0.701B 0.00
Xencor (XNCR) United States $0.680B 0.00
Liminatus Pharma (LIMN) United States $0.676B 0.00
AleAnna (ANNA) United States $0.589B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.575B 0.00
USANA Health Sciences (USNA) United States $0.555B 12.07
Bioventus (BVS) United States $0.552B 14.00
Theravance Biopharma (TBPH) United States $0.548B 0.00
Verve Therapeutics (VERV) United States $0.544B 0.00
Zevra Therapeutics (ZVRA) United States $0.503B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.485B 0.00
Altimmune (ALT) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Organogenesis (ORGO) United States $0.436B 0.00
Siga Technologies (SIGA) United States $0.433B 9.04
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.391B 10.56
Aquestive Therapeutics (AQST) United States $0.352B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.287B 0.00
ProKidney (PROK) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.73
Esperion Therapeutics (ESPR) United States $0.238B 0.00
MediWound (MDWD) Israel $0.232B 0.00
4D Molecular Therapeutics (FDMT) United States $0.222B 0.00
Nanobiotix S.A (NBTX) France $0.220B 0.00
Lyell Immunopharma (LYEL) United States $0.185B 0.00
OmniAb (OABI) United States $0.183B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Larimar Therapeutics (LRMR) United States $0.170B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Avita Medical (RCEL) United States $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.161B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.160B 0.00
Lexeo Therapeutics (LXEO) United States $0.145B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Fractyl Health (GUTS) United States $0.141B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Wellgistics Health (WGRX) United States $0.126B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Nektar Therapeutics (NKTR) United States $0.109B 0.00
Unicycive Therapeutics (UNCY) United States $0.109B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.095B 0.00
Champions Oncology (CSBR) United States $0.091B 15.00
VAXART, INC (VXRT) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 65.44
Nutriband (NTRB) United States $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
NRx Pharmaceuticals (NRXP) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Century Therapeutics (IPSC) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Jupiter Neurosciences (JUNS) United States $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Mannatech (MTEX) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Ainos (AIMD) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
SHINECO (SISI) China $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Klotho Neurosciences (KLTO) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00